Clinical Trial: Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654114) titled 'Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome' on June 12.

Brief Summary: The purpose of this Phase IIa study is to evaluate the safety, tolerability, and effectiveness of CTH120 in adult males with Fragile X syndrome.

Study Start Date: May 21

Study Type: INTERVENTIONAL

Condition: Fragile X Syndrome (FXS) Fragile X Syndrome

Intervention: DRUG: CTH120

15 participants will be randomized to receive CTH120 75 mg hard capsules. Capsules of CTH120 will be administered by the oral route to participants twice a day, one capsule in the morning and one capsule in the evening, at approximately the s...